合計 50 件の最近のインサイダー取引記録が記録されています Akoya Biosciences, Inc. (AKYA), 内訳は 23 件の買い および 26 件の売り. インサイダー買い総額は $3.92M インサイダー売り総額は $581.63K.
最近活動のある主要インサイダーには Bamford Pascal, Ek John Frederick, Ramachandran Niro Ph.d. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — AKYA
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2025-06-01 |
Bamford Pascal |
Chief Clinical Officer |
RSU 源泉徴収 |
670 |
$1.25 |
$837.50 |
205,738 |
| 2025-04-01 |
Ek John Frederick |
CFO |
RSU 源泉徴収 |
16,432 |
$1.35 |
$22.18K |
248,202 |
| 2025-03-23 |
Ramachandran Niro Ph.d |
Chief Business Officer |
RSU 源泉徴収 |
2,310 |
$1.70 |
$3.93K |
287,210 |
| 2025-03-23 |
Mckelligon Brian |
President and CEO |
RSU 源泉徴収 |
7,550 |
$1.70 |
$12.84K |
420,126 |
| 2025-03-01 |
Ek John Frederick |
CFO |
RSU 源泉徴収 |
3,594 |
$1.63 |
$5.86K |
264,634 |
| 2025-03-01 |
Ramachandran Niro Ph.d |
Chief Business Officer |
RSU 源泉徴収 |
3,594 |
$1.63 |
$5.86K |
289,520 |
| 2025-03-01 |
Mckelligon Brian |
President and CEO |
RSU 源泉徴収 |
8,257 |
$1.63 |
$13.46K |
427,676 |
| 2025-03-01 |
Kamocsay Jennifer |
Chief Legal Officer |
RSU 源泉徴収 |
3,594 |
$1.63 |
$5.86K |
179,272 |
| 2025-03-01 |
Bamford Pascal |
Chief Clinical Officer |
RSU 源泉徴収 |
2,567 |
$1.63 |
$4.18K |
206,408 |
| 2024-11-19 |
Ek John Frederick |
CFO |
RSU 付与（制限付株式） |
87,500 |
- |
- |
268,228 |
| 2024-11-19 |
Ramachandran Niro Ph.d |
Chief Business Officer |
RSU 付与（制限付株式） |
87,500 |
- |
- |
295,424 |
| 2024-11-19 |
Mckelligon Brian |
President and CEO |
RSU 付与（制限付株式） |
218,750 |
- |
- |
443,483 |
| 2024-11-19 |
Kamocsay Jennifer |
Chief Legal Officer |
RSU 付与（制限付株式） |
87,500 |
- |
- |
186,717 |
| 2024-11-19 |
Bamford Pascal |
Chief Clinical Officer |
RSU 付与（制限付株式） |
87,500 |
- |
- |
210,258 |
| 2024-10-02 |
Mendel Scott |
Director |
RSU 付与（制限付株式） |
44,959 |
$2.68 |
$120.49K |
44,959 |
| 2024-08-29 |
Bamford Pascal |
Chief Clinical Officer |
処分 |
15,000 |
$5.96 |
$89.4K |
- |
| 2024-08-29 |
Bamford Pascal |
Chief Clinical Officer |
RSU 付与（制限付株式） |
40,000 |
- |
- |
122,758 |
| 2024-06-11 |
Mckelligon Brian |
President and CEO |
情報に基づく売り |
7,500 |
$2.08 |
$15.63K |
224,733 |
| 2024-06-06 |
Mckelligon Brian |
President and CEO |
情報に基づく売り |
7,500 |
$2.01 |
$15.06K |
224,733 |
| 2024-06-04 |
Shepler Robert G |
Director |
RSU 付与（制限付株式） |
50,000 |
$2.01 |
$100.5K |
50,000 |
| 2024-06-04 |
Lai Goldman Myla |
Director |
RSU 付与（制限付株式） |
50,000 |
$2.01 |
$100.5K |
50,000 |
| 2024-06-04 |
Schnettler Thomas P |
Director |
RSU 付与（制限付株式） |
50,000 |
$2.01 |
$100.5K |
50,000 |
| 2024-06-04 |
Raffin Thomas A. |
Director |
RSU 付与（制限付株式） |
50,000 |
$2.01 |
$100.5K |
50,000 |
| 2024-06-04 |
Mendel Scott |
Director |
RSU 付与（制限付株式） |
50,000 |
$2.01 |
$100.5K |
50,000 |
| 2024-06-04 |
Winkler Matthew |
Director |
RSU 付与（制限付株式） |
50,000 |
$2.01 |
$100.5K |
50,000 |
| 2024-04-01 |
Ek John Frederick |
CFO |
RSU 源泉徴収 |
14,272 |
$4.56 |
$65.08K |
180,728 |
| 2024-03-23 |
Pla Frederic |
Chief Operating Officer |
RSU 源泉徴収 |
2,006 |
$4.79 |
$9.61K |
101,500 |
| 2024-03-23 |
Ramachandran Niro Ph.d |
Chief Business Officer |
RSU 源泉徴収 |
2,006 |
$4.79 |
$9.61K |
207,924 |
| 2024-03-23 |
Mckelligon Brian |
President and CEO |
RSU 源泉徴収 |
7,135 |
$4.79 |
$34.18K |
224,733 |
| 2024-03-20 |
Mckelligon Brian |
President and CEO |
情報に基づく売り |
7,500 |
$4.97 |
$37.24K |
231,868 |
| 2024-03-13 |
Shepler Robert G |
Director |
贈与（送付） |
369,592 |
- |
- |
- |
| 2024-03-13 |
Mckelligon Brian |
President and CEO |
情報に基づく売り |
7,500 |
$4.94 |
$37.04K |
224,368 |
| 2024-03-13 |
Mckelligon Brian |
President and CEO |
情報に基づく売り |
7,500 |
$4.94 |
$37.04K |
231,868 |
| 2024-03-01 |
Pla Frederic |
Chief Operating Officer |
RSU 源泉徴収 |
2,049 |
$6.03 |
$12.36K |
103,506 |
| 2024-03-01 |
Ramachandran Niro Ph.d |
Chief Business Officer |
RSU 源泉徴収 |
2,305 |
$6.03 |
$13.9K |
209,930 |
| 2024-03-01 |
Mckelligon Brian |
President and CEO |
RSU 源泉徴収 |
2,049 |
$6.03 |
$12.36K |
103,506 |
| 2024-03-01 |
Kamocsay Jennifer |
General Counsel |
RSU 源泉徴収 |
3,283 |
$6.03 |
$19.8K |
99,217 |
| 2024-02-22 |
Pla Frederic |
Chief Operating Officer |
RSU 付与（制限付株式） |
70,000 |
$5.35 |
$374.5K |
70,000 |
| 2024-02-22 |
Ek John Frederick |
CFO |
RSU 付与（制限付株式） |
70,000 |
$5.35 |
$374.5K |
70,000 |
| 2024-02-22 |
Ramachandran Niro Ph.d |
Chief Business Officer |
RSU 付与（制限付株式） |
70,000 |
$5.35 |
$374.5K |
70,000 |
| 2024-02-22 |
Mckelligon Brian |
President and CEO |
RSU 付与（制限付株式） |
175,000 |
$5.35 |
$936.25K |
175,000 |
| 2024-02-22 |
Kamocsay Jennifer |
General Counsel |
RSU 付与（制限付株式） |
70,000 |
$5.35 |
$374.5K |
70,000 |
| 2023-12-19 |
Mckelligon Brian |
President and CEO |
情報に基づく売り |
7,500 |
$4.48 |
$33.57K |
152,563 |
| 2023-12-12 |
Mckelligon Brian |
President and CEO |
情報に基づく売り |
7,500 |
$4.25 |
$31.87K |
152,563 |
| 2023-11-20 |
Mckelligon Brian |
President and CEO |
情報に基づく売り |
7,500 |
$4.39 |
$32.9K |
152,563 |
| 2023-11-06 |
Pla Frederic |
Chief Operating Officer |
RSU 付与（制限付株式） |
30,000 |
- |
- |
70,555 |
| 2023-11-06 |
Kamocsay Jennifer |
General Counsel |
RSU 付与（制限付株式） |
30,000 |
- |
- |
67,500 |
| 2023-09-07 |
Pla Frederic |
Chief Operating Officer |
情報に基づく買い |
13,000 |
$4.60 |
$59.81K |
13,000 |
| 2023-06-12 |
Shepler Robert G |
Director |
情報に基づく買い |
120,000 |
$5.00 |
$600K |
369,592 |
| 2023-06-12 |
Lai Goldman Myla |
Director |
情報に基づく買い |
20,000 |
$5.00 |
$100K |
20,000 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
